Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Lars Riedemann"'
Autor:
Ariel D Stern, PhD, Jan Brönneke, LLM, Jörg F Debatin, MD, Julia Hagen, MPA, Henrik Matthies, PhD, Smit Patel, PharmD, Ieuan Clay, PhD, Bjoern Eskofier, ProfPhD, Annika Herr, ProfPhD, Kurt Hoeller, PhD, Ashley Jaksa, MPH, Daniel B Kramer, MD, Mattias Kyhlstedt, Katherine T Lofgren, PhD, Nirosha Mahendraratnam, PhD, Holger Muehlan, PhD, Simon Reif, PhD, Lars Riedemann, MD, Jennifer C Goldsack, MA
Publikováno v:
The Lancet: Digital Health, Vol 4, Iss 3, Pp e200-e206 (2022)
Summary: In 2019, Germany passed the Digital Healthcare Act, which, among other things, created a “Fast-Track” regulatory and reimbursement pathway for digital health applications in the German market. The pathway explicitly provides for flexibil
Externí odkaz:
https://doaj.org/article/946b756032bc47a5b92f1ed2d9bfbfbd
Autor:
Vidya Gopalakrishnan, Laurence Cooper, Alvaro Laureano, Lars Riedemann, Martin Hasselblatt, Tobey MacDonald, Irene B. Helenowski, Stewart Goldman, Veena Rajaram, Jason Fangusaro, Pete Taylor
PDF file, 169KB, Measurement of Syn1 expression following SAHA treatment of murine NSC-M and NSC-MR cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40fd183ec3a5ff7ad5b0370f34979771
https://doi.org/10.1158/1535-7163.22497334
https://doi.org/10.1158/1535-7163.22497334
Autor:
Vidya Gopalakrishnan, Laurence Cooper, Alvaro Laureano, Lars Riedemann, Martin Hasselblatt, Tobey MacDonald, Irene B. Helenowski, Stewart Goldman, Veena Rajaram, Jason Fangusaro, Pete Taylor
PDF file, 73KB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75431aab145fde29960e4441d1d0e0ac
https://doi.org/10.1158/1535-7163.22497331.v1
https://doi.org/10.1158/1535-7163.22497331.v1
Autor:
Vidya Gopalakrishnan, Laurence Cooper, Alvaro Laureano, Lars Riedemann, Martin Hasselblatt, Tobey MacDonald, Irene B. Helenowski, Stewart Goldman, Veena Rajaram, Jason Fangusaro, Pete Taylor
Medulloblastoma is a malignant pediatric brain tumor. Current treatment following patient stratification into standard and high-risk groups using clinical features has improved survival. However, a subset of patients with standard risk features have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::916b05f8cc855609cff1f414e17805bc
https://doi.org/10.1158/1535-7163.c.6535585
https://doi.org/10.1158/1535-7163.c.6535585
Autor:
Vidya Gopalakrishnan, Laurence Cooper, Alvaro Laureano, Lars Riedemann, Martin Hasselblatt, Tobey MacDonald, Irene B. Helenowski, Stewart Goldman, Veena Rajaram, Jason Fangusaro, Pete Taylor
PDF file, 338KB, Table1A. Overview of Database; Table 1B. Event Free Survival (EFS); Table 1C. Overall Survival (OS).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::426aff850841de23124537f2a986cc7f
https://doi.org/10.1158/1535-7163.22497325
https://doi.org/10.1158/1535-7163.22497325
Autor:
Mona Laible, Sina Burth, Mona Ohmann, Lars Riedemann, Antje Wick, Timolaos Rizos, Meinhard Kieser, Wolfgang Wick, Simon Nagel, Dorothea Kronsteiner, Anne Berberich, Sarah Löw, Katharina Drüschler, Frank Winkler
Publikováno v:
Journal of Neuro-Oncology
Purpose Patients with glioblastoma (GBM) or brain metastases (MET) and atrial fibrillation (AF) might be at an increased risk of intracranial hemorrhage (ICH) due to anticoagulation (AC). Our aim was to assess this risk. Methods Our institution’s d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f22656b37d8e29d160fa4612ecaa076
https://doi.org/10.1007/s11060-021-03716-8
https://doi.org/10.1007/s11060-021-03716-8
Autor:
Ariel D Stern, Jan Brönneke, Jörg F Debatin, Julia Hagen, Henrik Matthies, Smit Patel, Ieuan Clay, Bjoern Eskofier, Annika Herr, Kurt Hoeller, Ashley Jaksa, Daniel B Kramer, Mattias Kyhlstedt, Katherine T Lofgren, Nirosha Mahendraratnam, Holger Muehlan, Simon Reif, Lars Riedemann, Jennifer C Goldsack
Publikováno v:
The Lancet. Digital health. 4(3)
In 2019, Germany passed the Digital Healthcare Act, which, among other things, created a "Fast-Track" regulatory and reimbursement pathway for digital health applications in the German market. The pathway explicitly provides for flexibility in how re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a526a3145738bbb092874c2574eafe92
https://pubmed.ncbi.nlm.nih.gov/35216754
https://pubmed.ncbi.nlm.nih.gov/35216754
Autor:
Wolfgang Wick, Michael O. Breckwoldt, Thomas Schmidt, Moritz J. Strowitzki, Michael Thomas, Frederik Marmé, Marc Cinci, Dirk Jäger, Laura Michel, Lars Riedemann, Kianush Karimian-Jazi, Anna S. Berghoff, Frank Winkler, Martin Bendszus, Matthias Preusser, Julia Furtner, Sarah Loew, Franziska Schlieter
Publikováno v:
Neuro-oncology Advances
Background Salvage treatment for recurrent brain metastases (BM) of solid cancers is challenging due to the high symptomatic burden and the limited local treatment options. Methods Patients with recurrent BM with no option for further local therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fc51370124e368f8b790a91e6536370
https://pubmed.ncbi.nlm.nih.gov/32642693
https://pubmed.ncbi.nlm.nih.gov/32642693
Autor:
Anne Berberich, Felix Sahm, Lars Riedemann, Thomas Hielscher, Marlene Arzt, Frank Winkler, Andreas von Deimling, Philipp Kickingereder, Antje Wick, Michael Platten, Wolfgang Wick, Katharina Drüschler, Tobias Kessler, Martin Bendszus
Publikováno v:
International journal of radiation oncology, biology, physics. 102(5)
Purpose Because treatment options at progression are limited for patients with glioma, accuracy in definition of progression is pivotal. Clinically asymptomatic, newly detected, nonmeasurable, speckled contrast-enhancing lesions (SCEs) without immedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43e04d4b7855ad86260cbb4a2605d751
https://pubmed.ncbi.nlm.nih.gov/30071292
https://pubmed.ncbi.nlm.nih.gov/30071292
Autor:
Vasileios Askoxylakis, Lars Riedemann, Nan Lin, Shanmugarajan Krishnan, Rakesh K. Jain, Meenal Datta, Marco C. Pinho, Alan J. Grodzinsky, Peigen Huang, James W. Baish, Timothy P. Padera, Mitrajit Ghosh, Dai Fukumura, Hadi Tavakoli Nia, Patrick Y. Wen, Tracy T. Batchelor, Giorgio Seano, Kyrre E. Emblem, Jun Ren, Lance L. Munn, Gino B. Ferraro, Elizabeth R. Gerstner, Jonas Kloepper
Publikováno v:
Neuro-oncology Advances
The compression of brain tissue by a tumor mass is believed to be a major cause of the clinical symptoms seen in patients. However, the biological consequences of these physical stresses on the brain tissue are unknown. Using clinical imaging and pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::276fb28c9407ba5b3f8ccedbd8460b10
http://europepmc.org/articles/PMC7213330
http://europepmc.org/articles/PMC7213330